Physician profile
Courtney K Brightman
NPI 1780772814
$2,003.38
in general payments reported to CMS, 2019-2025
11 companies · $888 in 2025
The $888 reported for 2025 was more than what 90% of Pediatrics (Optometrist) providers received nationally (typical 2025 total: $152).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.10 · 2020: $18.10 · 2021: $146 · 2022: $451 · 2023: $169 · 2024: $318 · 2025: $888.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,375.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $492.29 | 2022-2025 | Xiidra, Miebo |
| Alcon Vision LLC | $474.89 | 2021-2025 | Precision7, Total30 |
| Sun Pharmaceutical Industries INC. | $266.21 | 2021-2025 | |
| Glaukos Corporation | $215.37 | 2025 | Photrexa Viscous and Photrexa, Kxl System (Not Refurbished) |
| Johnson & Johnson Vision Care, INC. | $153.25 | 2022-2023 | Acuvue |
| Dompe US, INC. | $139.28 | 2024-2025 | Oxervate |
| Oyster Point Pharma, INC. | $99.72 | 2022-2023 | Tyrvaya |
| Abbvie INC. | $56.63 | 2022 | |
| Allergan, INC. | $41.36 | 2022 | |
| Kala Pharmaceuticals, INC. | $34.18 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $30.20 | 2019-2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Courtney Brightman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.